Benefits of an Intervention Combining Hypnosis and Self-care for Prostate Cancer Patients
- Conditions
- Prostate Cancer
- Interventions
- Behavioral: Self-hypnosis + Self-care
- Registration Number
- NCT03423927
- Lead Sponsor
- University of Liege
- Brief Summary
This study aims to assess the impact of a group intervention combining self-hypnosis and self-care techniques on prostate patients' well-being. More specifically, the investigators want to investigate the effects of that intervention on sleep, fatigue and emotional distress of the patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 46
- 18-years-old,
- ability to read, write and speak French
- prostate cancer diagnosis
- treatment with surgery and/or radiotherapy.
- metastases
- cancer recurrence at the moment of inclusion
- major cognitive or psychiatric disorder.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intervention group : hypnosis + self-care Self-hypnosis + Self-care Groupal intervention combining self-care techniques and self-hypnosis exercises
- Primary Outcome Measures
Name Time Method Change in Fatigue T0 (before the intervention) and T1 (after the intervention : 6 months later). A sense of tiredness or exhaustion linked with cancer and its treatments, that is not alleviated by sleep. Measured by the European Organization for Research and Treatment of Cancer - Quality of Life Core Questionnaire-30 (EORTC-QLCQ30). One symptom-related scale (fatigue, score based on 3 items, varies from 0 to 100, 100 being the worst fatigue endured) and the global health status (2 items, score varies from 0 to 100, 100 being the best quality of life) are used in this study.
Change in emotional distress T0 (before the intervention) and T1 (after the intervention : 6 months later). Anxiety + Depression, measured with the Hospital Anxiety and Depression Scale (HADS). Scores range (total): 0-42 (0-14: absence of anxio-depressive disorder ; 15-42: presence of anxio-depressive disorder). Two scales: anxiety and depression. For each, scores range 0-21 (0-7: absence of anxious or depressive disorder; 8-10: possibility of an anxious or depressive disorder; 11-21: presence of anxious or depressive disorder).
Change in sleep difficulties T0 (before the intervention) and T1 (after the intervention : 6 months later). Sleep difficulties (difficulties to stay asleep, to fall asleep...) and their severity. Measured by the Insomnia Severity Index. One score is calculated and ranges from 0 to 22 (0-7: absence of insomnia; 8-14: subclinical insomnia; 15-21: moderate insomnia; 22-28: severe insomnia).
- Secondary Outcome Measures
Name Time Method